Anti-Ageing Therapies

Size: px
Start display at page:

Download "Anti-Ageing Therapies"

Transcription

1 We were treated like royalty. Everything went very smoothly. The conference was a credit to the SMi team. Speaker, Pharmaceutical Conference, February 2002 Discover exciting new developments in Anti-Ageing Therapies 23rd & 24th October 2002, The Hatton, London A closer look at what we know about the ageing process and how it relates to age-associated diseases and their treatments Benefits of Attending UNDERSTAND the complexities of the ageing process KEEP UP TO DATE with the very latest developments in the treatment of ageing and age-related diseases, such as Alzheimer s disease, Parkinson s disease, dementia and cancer LEARN about the causes and effects of ageing in terms of identifying viable targets for new therapies E VA L U ATE the potential for developing therapeutics against ageing and responding to increasing consumer demand in an ageing population MEET key decision makers and make valuable industry contacts A unique opportunity to learn from leading industry experts including: Dr Jan Nehlin, Research Associate Professor, Novo Nordisk Dr Kenneth Sommerville, Neuroscience Medical Director, Abbott Laboratories Dr Stanley Shapiro, Vice President, Science and Technology, Johnson & Johnson Dr Bruce Gitter, Senior Research Scientist, Eli Lilly Charles Studer, Vice President, Novartis Foundation for Gerontology Dr Calvin Harley, Chief Scientific Officer, Geron Dr Bernard Malfroy-Camine, President & Chief Executive Officer, Eukarion PLUS A FULL DAY EXECUTIVE BRIEFING Genomics and Our Understanding of the Ageing Process 25th October 2002, The Hatton, London In association with: w w w. s m i - o n l i n e. c o. u k / a n t i a g e i n g. a s p Register online and receive full information on all of SMi s confere n c e s Or alternatively fax your re g i s t ration to +44 (0) Or call +44 (0) % DISCOUNT Academic Researchers receive 50% discount Supported by

2 w w w. s m i - o n l i n e. c o. u k / a n t i a g e i n g. a s p Register online and receive full information on all of SMi s confere n c e s Or alternatively fax your re g i s t ration to +44 (0) or call +44 (0) Registration & Coffee 9.00 Chairman's Opening Remarks Including a short talk on CARNOSINE PLURIPOTENCY AND ANTI-AGEING AGENTS Dr Alan Hipkiss, Senior Lecturer, Biochemistry, King s College London UNDERSTANDING THE AGEING PROCESS ANTI-AGEING THERAPEUTICS: AN INTRODUCTION 9.20 Strategic approaches to anti-ageing therapeutics Should one develop therapies for ageing or age-related diseases? Major proposed causes of ageing Summary of recent data supporting each cause of ageing Causes versus effects: does treating effects of ageing help? Therapies that address each proposed cause of ageing Best anti-ageing targets based on current data Dr Bryant Villeponteau, President & Chief Scientific Officer, HealthSpan Sciences ENDOCRINOLOGY OF AGEING 9.50 Disarray of endocrine systems in the ageing human Many hormones decline in their frequency, strength and production as we age What are the underlying mechanisms responsible? Relative magnitudes and time courses of different endocrine adaptations in the ageing human and in experimental animals The current focuses: HGH, DHEA, cortisol, melatonin, thyroid hormone and thymic hormones Targeting hormone precursors for anti-ageing therapies Implications of therapeutic reconstitution with hormones in the aged Dr Jan Nehlin, Scientist & Research Associate Professor, Novo Nordisk SLOWING DOWN AGEING FROM WITHIN Applying hormesis in biogerontology Gerontogenes Vitagenes Failure of maintenance Homeostasis and homeodynamics Stress response Healthy ageing Prof Suresh Rattan, Professor, Danish Centre for Molecular Gerontology, University of Aarhus Morning Coffee PHARMACOLOGICAL INTERVENTION AND TREATING THE AGEING DISORDER OXIDATIVE DAMAGE AND TARGETING ANTI-AGEING THERAPIES The fight against reactive oxygen species Understanding oxidative stress and its role in pathogenesis and ageing The anti-oxidant defence system Pharmacological intervention to counteract oxidative stress: synthetic catalytic scavengers Studies in animal models for diseases associated with ageing Clinical development programs Is oxidative stress one key to future research into ageing and age-related diseases? Dr Bernard Malfroy-Camine, President & Chief Executive Officer, Eukarion OXIDATIVE STRESS PROFILE Understanding the role of oxidative stress in the ageing process Longevity determinant genes and the dysdifferentiation hypothesis of ageing Evidence for primary ageing and primary anti-ageing processes The genetic complexity governing human ageing rate Oxidative stress represents a primary ageing process Processes governing oxidative stress status control stability of the differentiated cell Stability of the transcription/translation profile of cells govern whole organism ageing rate Determining the oxidative stress/antioxidant profile of patients Using the oxidative stress profile to create customised dietary supplements Demonstration that dietary supplements reduce patients oxidative stress status The Kronos Laboratory tests and optimum health program Dr Richard Cutler, Senior Scientist, Exeter Life Sciences/ Kronos Longevity Research Institute Networking Lunch MITOCHONDRIA AND LYSOSOMES IN PRIMARY MECHANISMS OF HUMAN AGEING 2.00 Developing drugs and gene therapies for post-mitotic cells Turnover of proteins and mitochondria in post-mitotic cells: decline with age Lipofuscin origins and consequences Mitochondrial DNA mutations take over cells Energy crisis and redox stress cause cell senescence and cell death Damage to the brain, heart and skeletal muscle Design of targeted therapies John Furber, Founder, Legendary Pharmaceuticals MITOCHONDRIAL DYSFUNCTION IN AGEING AND DISEASE 2.40 Novel polycyclic phenols as therapeutics Mitochondrial function and dysfunction in ageing Oxidative mitochondrial pathology and failure Mitochondrial contributions to disease (type 2 diabetes; Alzheimer s and Parkinson s diseases; glaucoma) Polycyclic phenols (PPCs) as drug development candidates Mechanisms of action and SAR Mitochondrial consequences of PPC treatment New directions and indications Dr James Dykens, Senior Scientist, Associate Director, Business & Corporate Development, Mitokor 3.20 Afternoon Tea DRUG TARGETING AND TELOMERASE 3.40 The telomere time keeper and the potential of telomerase for degenerative conditions of ageing Telomeres in the regulation of cellular senescence The shortening of telomeres appears to be the cellular clock that controls the ageing of our cells The telomere and telomerase connection Four approaches for killing telomerase-positive cells as cancer therapy Progress towards development of telomerase activators for degenerative conditions of ageing Dr Calvin Harley, Chief Scientific Officer, Geron THE CLOCK THAT WOULDN T BE BEATEN 4.20 Controlling the length of our telomeres An exclusive focus on developing therapeutics for treating ageing-related diseases Regulation of the human telomerase promotor to affect telomere length (the clock of ageing) Complete mutation map of the telomerase minimal promoter Strong repressor site identified Other telomerase gene regulatory elements identified Dr Bill Andrews, Founder & Vice President, Research, Sierra Sciences 5.00 Chairman s Closing Remarks and Close of Day One Supported by Pharma-i.com is the only community for the pharmaceutical, biotechnology, healthcare and related life sciences professional live on the Internet. This unique site features a rich mix of pharmaceutical industry news, drug research, clinical trial updates, product news, an events diary, the latest market research, discussion forums, e-commerce centres, and much more... Our 6,000 regular users include: Eli Lilly, Procter & Gamble, Novartis, Aventis, Pfizer, Parke-Davis, GSK, Merck & Co., Roche, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Boehringer-Ingelheim, ICN Pharmaceuticals, Bayer, Solvay, Sanofi-Synthelabo, Ortho-McNeil, Yamanouchi, Byk Gulden, Rhone-Poulenc, Teva Pharmaceutical, Whitehall-Robins, Bayer, Servier Laboratories, Knoll, Janssen, Schering Health Care, Ipsen Limited, Du Pont Pharma, McNeil Consumer Healthcare, BioSante, and Genesis. Users include a wide range of senior executives in: clinical research, drug design, drug discovery, validation, lab equipment, compliance, quality assurance, regulation, licensing, drug delivery, gene therapy, biotechnology, pharmacoeconomics, bioinformatics, proteonomics, nutraceuticals, wholesale/distribution, sales/marketing, CROs, active ingredients, and medical devices. Want to know how you can get involved? Interested in promoting your pharmaceutical services to this market? Call Jacqueline Antill, SMi Marketing on +44 (0) or Do you want to contact more than 25,000 key decision makers around the world with a targeted campaign? Target your marketing message directly to Clinical R&D Directors/Managers and their Teams. Please visit for more information. Complete the online form in the Marketing Services section to receive a detailed breakdown of the numbers available and a price for your send. Tel:+44 (0) , Fax: +44 (0) , Web:

3 w w w. s m i - o n l i n e. c o. u k / a n t i a g e i n g. a s p Register online and receive full information on all of SMi s confere n c e s Or alternatively fax your re g i s t ration to +44 (0) or call +44 (0) Re-registration & Coffee Networking Lunch 9.00 Chairman's Opening Remarks Dr Wilfried Bieger, Private Practice, ANT.OX THE AGEING BRAIN THE AGEING BRAIN AND ALZHEIMER S DISEASE 9.10 Brain dysfunction affecting the lives of millions as they grow old: a closer look at Alzheimer s Alzheimer s disease: the most common cause of dementia among older people Using in vitro cell and transgenic animal models to investigate the amyloid hypothesis of Alzheimer s disease pathogenesis Understanding the role of amyloid precursor protein (APP) processing enzymes in the production, deposition and clearance of brain Aß deposits Alternative strategies to reduce brain Aß deposits and reverse cognitive deficits in transgenic animal models of APP over expression Dr Bruce Gitter, Senior Research Scientist, Eli Lilly OXIGON TM : DUAL MECHANISM APPROACH TO THE TREATMENT OF ALZHEIMER S DISEASE 9.40 Targeting the beta-amyloid cascade in Alzheimer s disease The central role of beta-amyloid cascade in AD Oxidative stress in AD Therapeutic strategies for AD Complexities of trial design in AD: symptomatic versus disease modifying therapies OXIGON TM : a potent neuroprotective molecule Prof Paul Bendheim, Executive Vice President & Chief Medical Officer, Mindset BioPharmaceuticals A PROMISING ANTI-AMYLOID APPROACH TO ALZHEIMER S DISEASE THERAPY Gag mimetics Glycosaminoglycans (GAGs) promote amyloid formation GAG mimetics bind to amyloid protein and block amyloid formation in animal model of AD GAG mimetics reduce brain inflammation associated with amyloid deposits GAG mimetics: an oral drug candidate with a promising safety profile in clinical phase I trials Dr Francine Gervais, Vice President, Research & Development, Neurochem Morning Coffee BRAIN AGEING AND GLUTAMATE Positive modulation of glutamatergic transmission: a promising therapeutic target Glutamate: the primary neurotransmitter in the mammalian brain for excitatory communication AMPA receptor activity: its significance for cognitive function How much potentiation is enough: how much is too much? Ampakines: increased neutrophin (BDNF and NGF) expression to slow brain ageing Ampalex: the effects of CX516 in the elderly with mild cognitive impairment Dr Gary Rogers, Senior Vice President, Pharmaceutical Research, Cortex Pharmaceuticals DIVALPROEX (DEPAKOTE) IN DEMENTIA Clinical data and future directions Divalproex has shown effectiveness in treating agitation in dementia in clinical trials Divalproex dosing needs to be followed carefully in the elderly with dementia Divalproex may have properties to slow the progression Future directions in research with divalproex in dementia Dr Kenneth Sommerville, Neuroscience Medical Director, Abbott Laboratories THE AGEING SKIN AGEING SKIN 2.00 Dermatological care to reverse skin damage Signs of ageing primarily caused by photo damage How does our skin change: the dangers of skin immunosuppression Synthetic phenolic hormones with anti-inflammatory and immunostimulatory properties Topical application: the potential for protection against UV-induced skin damage and as an anti-ageing formulation So called anti-ageing creams that temporarily moisturise the skin but do not reverse damage Case study: NV-07a: the ability to undo skin damage following UV exposure Prof Alan Husband, Research Director, Novogen NEW TECHNOLOGICAL SOLUTIONS TO YOUNGER SKIN 2.40 Case study: Renova The quest for young looking skin: the need for medical intervention The look good generation and tapping into the cosmeceutical market Intrinsic and extrinsic factors responsible for skin ageing Common active ingredients to defy signs of ageing ReNova as a skin rejuvenation treatment Dr Stanley Shapiro, Vice President, Science and Technology, Johnson & Johnson 3.20 Afternoon Tea GENE AND CELL THERAPIES FOR AGE-RELATED DISEASES CELL THERAPY FOR AGE-RELATED DISEASES 3.40 Gene and cell therapy for age-related disease Stem cells Cell replacement Host vs. graft reaction Safety Functionality Regulatory hurdles Dr Don Kleinsek, Chief Executive Officer, GeriGene Medical A LOOK AT HOW ANTI-AGEING THERAPIES AND LIFESTYLE CHANGES CAN BE INTEGRATED ANTI-AGEING AND HEALTH EDUCATION 4.20 Using pharmacological therapies in conjunction with lifestyle changes Ageing is risky Major risk factors in an ageing population The role of education and informing the older person Experience with health promotion on the internet Working towards a healthier old age: how can we combine anti-ageing drugs and lifestyle changes to maximise quality of life for the elderly? Charles Studer, Vice President, Novartis Foundation for Gerontology 5.00 Chairman's Closing Remarks and Close of Conference SPONSORSHIP AND EXHIBITION OPPORTUNITIES SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company's marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call: Jackie McDonald, SMi Sponsorship on +44 (0) or

4 PHARMACEUTICAL FORWARD PLANNER MAY /30 Advances in hypertension and cardiovascular therapeutics JUNE /11 Pain Therapeutics 17/18 Therapeutic Antibodies 26/27 Neurodegenerative Disorders SEPTEMBER /24 Commercial Issues in Drug Delivery 30/1 Oct Clinical Trials & Data Management OCTOBER /03 Signal Transduction Therapeutics 09/10 Pharmacogenomics 14/15 From Hit to Lead Optimising Drug Development 16/17 Prevention & Treatment of Allergy 21/22 Pricing & Reimbursement in the Pharmaceutical Industry 23/24 Anti-Ageing Therapies 28/29 Diabetes NOVEMBER /07 Clinical Trials in CNS 18/19 Wholesale Distribution in the Pharmaceutical Industry 18/19 Tissue Engineering 20/21 Blood & Drugs DECEMBER /03 Vaccines 04/05 Dermatology

5 Genomics and Our Understanding of the Ageing Process 25th October 2002, The Hatton, London In association with: This briefing will take a look at the curre n t theories on why we age and how we can determine the way in which ageing is dictated by our genetic code. In a series of discussion sessions, the briefing will evaluate how we can go about i n c reasing our knowledge of the genomics of ageing and longevity and the problems that may be encountered along the way Registration & Coffee 9.00 Genomics and ageing: an overview Theories of ageing Model systems Morning Coffee Age-related changes in gene expression Transcriptional analysis of gene expression Proteomic approaches to ageing Lunch 2.00 Genomic approaches to human longevity Difficulties with studying ageing in humans Identification of longevity loci 3.45 Afternoon Tea 4.00 Bringing it together: a system s approach to ageing Synthesis of data from diverse sources Developing a molecular mechanism of ageing 5.15 Discussion and questions: review of session 5.30 Close of Briefing About your briefing leader Dr Matt Kaeberlein is a recognised authority in the field of ageing and longevity research. He has done extensive analyses of the molecular mechanisms of ageing and longevity in various biological systems and is an author of numerous scientific articles in the field. He is an advisor and database curator for the Science of Aging Knowledge Environment. As Vice President of Research at Longenity, Dr Kaeberlein is leading the scientific team in their work to discover treatments for age-associated diseases and disorders. About the company Longenity is a biotechnology company using genomics, bioinformatics, and systems biology to understand the ageing process in humans. Our goal is to develop treatments that slow ageing and remediate the symptoms associated with old age.

6 REGISTRATION FORM Conference: 23rd & 24th October 2002 Executive Briefing: 25th October % DISCOUNT Academic Researchers will receive 50% discount on marked price Proof of status to be sent with registration Unique Reference Code Your purchase order no PLEASE USE BLOCK PRINT - PLEASE COMPLETE FORM IN FULL T i t l e F o re n a m e I n i t i a l s S u r n a m e D e p a r t m e n t Job Title O rg a n i s a t i o n A d d ress To w n / C i t y C o u n t y Post/Zip code C o u n t r y D i rect Phone D i rect Fax S w i t c h b o a rd Phone S w i t c h b o a rd Fax E m a i l Booking Contact Job Title Immediate Manager Business Sector Number of employees on site Signature I agree to SMi Conferences Ltd Terms and Conditions of Booking. Please register the following delegates for (photocopy for multiple registrations) Anti-Ageing Therapies 23rd 25th October 2002, The Hatton, London Date I cannot attend the conference but wish to purchase: 300 Documentation (including postage and packing) 500 Documentation and Audio Tapes (including VAT, postage and packaging) To order, complete the Registration Form and complete your method of payment. Payment must be received before the goods can be despatched which will be 7-14 days after the conference. PAYMENT: I enclose a cheque (drawn on a UK Bank made payable to SMi Conferences Ltd) I am transferring the money to HSBC Bank plc, Account No: , Sort Code: (For overseas customers please use SWIFT CODE MIDLGB22) 28 Borough High Street, London SE1 1YB Please debit my credit card (including % & tax) Visa/MasterCard (1.90%) Amex (3.80%) Diners (3.00%) Eurocard (1.90%) Card No Expiry Date Signature Date I agree to SMi Conferences Ltd Terms and Conditions of booking and SMi debiting my credit card. EXECUTIVE PACKAGES For our Executive package inclusive of a discount of 100, tick below: Option A Conference & Executive Briefing Fee: VAT: Total: Tick here for either the conference or executive briefing but not both: Option B Conference only Fee: VAT: Total: Option C Executive Briefing only Fee: VAT: Total: ACADEMIC DISCOUNT Option D Conference only Fee: VAT: Total: How to register: By mail: Complete and return your signed Registration Form together with your cheque to: SMi Conferences Ltd, 1 New Concordia Wharf, Mill St, London SE1 2BB By fax: Complete and fax your signed Registration Form with your credit card details to +44 (0) By internet: Complete your Registration Form online with your credit card details at How to contact us: Telephone: +44 (0) Fax: +44 (0) Web: How we will contact you: SMi Conferences Ltd s preferred method of communication is by and phone. Please ensure you complete the Registration Form so that we can contact you. We will use postal services on a request basis only. Venue: The Hatton, Hatton Garden, London EC1N 8HN. The Hatton is SMi Conferences Ltd s bespoke state of the art conference venue and has excellent transport links to all London airports, with train and tube stations nearby. There are also three NCP car parks in close proximity. Full details will be included in your conference joining pack. We can arrange your travel, accommodation, transfers and insurance. The SMi JVT team are available to make your journey and stay during the conference as hassle free and as smooth as possible. SMi JVT can book your accommodation, flights, transfers and arrange insurance all at the best possible rate. Please contact us on +44 (0) fax +44 (0) or visit our website Please book early to get the full advantage of our travel packages. Payment terms: SMi Conferences Ltd require the full amount to be settled prior to the event taking place. SMi Conferences Ltd reserves the right to refuse entry to any customer who has not paid their invoice. A credit card guarantee may be requested if full payment has not been received. Methods of payment: Payment must be in sterling. You can pay by cheque drawn on a UK bank, payable to SMi Conferences Ltd or by bank transfer to HSBC Account No: Sort Code: (For overseas customers please use SWIFTCODE MIDLGB22) 28 Borough High St, London SE1 1YB, or by credit card. Please complete the Registration Form. When making payments please quote delegate s name and conference and/or product. Interest: SMi Conferences Ltd reserves the right to charge interest on any unpaid invoices. SPONSORSHIP OPPORTUNITIES Jackie McDonald, SMi Sponsorship on +44 (0) or MARKETING OPPORTUNITIES Jacqueline Antill, SMi Marketing on +44 (0) or Alteration to invoices: Any alterations to an invoice, excluding substitutions/names changes, requested by the customer will incur an administration fee of 50 and will be charged to the customer by credit card prior to the amendment being made. Cancellations/substitutions and name changes: All bookings carry a 50% liability after the booking has been made, by post, fax, or web. There will be no refunds for cancellations received on or after one month before the start of the conference (e.g. cancellation on or after 20th January for a conference starting on 20th February). If you decide to cancel after this date the full invoice remains payable. Conference notes which are available on the day will be sent to you. Unfortunately we are not able to transfer places between conferences and conferences and workshops. However, if you are unable to attend the event you may make a substitution/name change at any time as long as we are informed in writing by , fax or post. Name changes and substitutions must be from the same company and are not transferable between companies or countries. Indemnity: SMi Conferences Ltd reserve the right to change the conference/workshop content, timing, speakers or venue without notice. The event may be postponed or cancelled due to acts of terrorism, war, extreme weather conditions, industrial action, acts of God or any event beyond the control of SMi Conferences Ltd. If such a situation arises we will endeavour to reschedule the event. However, SMi Conferences Ltd cannot be held responsible for any cost, damage or expenses which may be incurred by the customer as a consequence of the event being postponed or cancelled. We therefore strongly advise all customers to take out insurance to cover the cost of the registration, travel and expenses. SMi JVT can provide this insurance. Data Protection: SMi Conferences Ltd (part of the SMi Group Ltd) gathers data in accordance with the UK Data Protection Act The information about you contained on this form may be used to update you on SMi Group products and services via post, telephone, fax or , unless you state that you do not want us to do so. We may also share your data with other companies within the SMi Group, or external companies offering complementary products or services. If you do not wish for your details to be passed on to any external third party, or if you have any queries regarding the data we hold on you, please contact our Database Manager SMi Information Services Ltd (part of the SMi Group Ltd), 1 New Concordia Wharf, Mill St, London, SE1 2BB, United Kingdom. The fee includes lunch, refreshments and conference papers provided on the day. It does not include travel, hotel accommodation, transfers or insurance (which we strongly recommend you obtain). VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT incurred by contacting Eurocash Corporation plc (0) , Eurocash are specialists in recovering cross border VAT. If you have NOT received re g i s t ration confirmation within 48 hours of registering, please call +44 (0)

Changes in the Brain

Changes in the Brain Alzheimer s Disease Alzheimer s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most

More information

Nerium International: St. Louis 16

Nerium International: St. Louis 16 Nerium International: St. Louis 16 Discovering novel small molecule therapeutics to modulate signal transduction imbalances. Signum Biosciences Founders Dr. Jeffry B. Stock PROFESSOR, PRINCETON UNIVERSITY

More information

Pharmacology skills for drug discovery. Why is pharmacology important?

Pharmacology skills for drug discovery. Why is pharmacology important? skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th

More information

EFPIA Position Paper on REACH. Executive Summary. Position Paper. Draft Final. Author: EFPIA Date: October 2015 Version: Final

EFPIA Position Paper on REACH. Executive Summary. Position Paper. Draft Final. Author: EFPIA Date: October 2015 Version: Final Draft Final EFPIA Position Paper on REACH Author: EFPIA Date: October 2015 Version: Final Position Paper Executive Summary An increasing number of substances used in the pharmaceutical manufacturing process

More information

There are both sponsorship and exhibition opportunities at the meeting, detailed in the document below.

There are both sponsorship and exhibition opportunities at the meeting, detailed in the document below. Dear Prospective Exhibitor! We would like to extend to you an invitation to join us at the Society for Experimental Biology s Annual Main Meeting 2011 taking place from the 1 st 4 th July 2011 in Glasgow,

More information

Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America (PNAS)

Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America (PNAS) Accelerated telomere shortening in response to life stress 1 Proceedings of the National Academy of Sciences of the United States of America (PNAS) December 7, 2004, Vol. 101, No. 49 17312-17315 Elissa

More information

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose

More information

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Tariq Sadat PhD Candidate School of Economics, Finance and Marketing, RMIT University, Australia Roslyn

More information

The course is sponsored by pharmaceutical / other companies, which may be present on the day with exhibition stands

The course is sponsored by pharmaceutical / other companies, which may be present on the day with exhibition stands 5 th Guildford Advanced Pain & Symptom Management Courses 5 th -6 th September 2016 University of Surrey, Guildford 19 th -20 th September 2016 Midland Hotel, Manchester Background David Sackett and colleagues

More information

Professor Rajesh Chandra Vice-Chancellor & President UNIVERSITY OF THE SOUTH PACIFIC

Professor Rajesh Chandra Vice-Chancellor & President UNIVERSITY OF THE SOUTH PACIFIC Business Improvement in Universities Realigning services to drive efficiency 15th & 16th June 2016, CQ Functions Melbourne Key Speakers Benefits of attending Paul Duldig Head of University Services THE

More information

Alzheimer Disease (AD)

Alzheimer Disease (AD) 1 Alzheimer Disease (AD) 2 Alzheimer's disease is a progressive degenerative disease that attacks the brain and results in impaired memory, thinking and behavior. It was first described by Dr. Alois Alzheimer

More information

Volcker Rule Breakfast Briefing

Volcker Rule Breakfast Briefing Volcker Rule Breakfast Briefing Venue: Date: Pinners Hall, 105-108 Old Broad Street, London, EC2N IEX 7 April 2014 Volcker and cross-border bank resolution Speakers include: Barnabas Reynolds Head of the

More information

Master of Science in Biomedical Sciences

Master of Science in Biomedical Sciences Master of Science in Biomedical Sciences Faculty of Medicine Good health is our greatest treasure. Understanding the human body, healthy and diseased, is the stepping stone to finding tools to improving

More information

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can

More information

Business Improvement in Universities

Business Improvement in Universities Business Improvement in Universities Transforming back-of-house functions to maximise efficiency gains 24th & 25th September, 2014, Rydges Melbourne Key Speakers Benefits of attending Peter Marshall Chief

More information

If you were diagnosed with cancer today, what would your chances of survival be?

If you were diagnosed with cancer today, what would your chances of survival be? Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

Exhibitors. Key Speakers:

Exhibitors. Key Speakers: Key Speakers: Paul Dolin, Head of Pharmacoepidemiology, Takeda Pharmaceuticals Sandip Chaudhari, Senior Director and Clinical Safety and Risk Management, Pfizer Dr. Katrin Freund, Project Excellence Manager

More information

Human Health Sciences

Human Health Sciences Human Health Sciences WITH PLYMOUTH UNIVERSITY DISCOVER MORE If you would like to visit Plymouth and meet our staff, then why not come along to one of our open days. Human Health Sciences WITH PLYMOUTH

More information

Participating in Alzheimer s Disease Clinical Trials and Studies

Participating in Alzheimer s Disease Clinical Trials and Studies Participating in Alzheimer s Disease Clinical Trials and Studies FACT SHEET When Margaret was diagnosed with earlystage Alzheimer s disease at age 68, she wanted to do everything possible to combat the

More information

European Epidemiological Forum

European Epidemiological Forum European Epidemiological Forum Observational Research and Pharmacoepidemiology in Europe: deeper insights to drive health research and discovery Amsterdam,The Netherlands Hyatt Place Amsterdam Airport

More information

Key Advances in Stroke Rehabilitation

Key Advances in Stroke Rehabilitation Conference on Key Advances in Stroke Rehabilitation 12th June 2013 Organised by: Congress Centre, London United Kingdom Limited spaces available Key Advances in Stroke Rehabilitation About the conference

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

ADVANCED STRESS TESTING

ADVANCED STRESS TESTING SYDNEY 15 & 16 SEPTEMBER 2008 T R A I N I N G ADVANCED STRESS TESTING Course Highlights: Course Tutors: Efficiently analysing, reporting and communicating stress test results The problem with haircuts

More information

Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany

Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

Coenzyme Q10. Information Sheet

Coenzyme Q10. Information Sheet Coenzyme Q10 What is Coenzyme Q10? Coenzyme Q10 (or CoQ10) is a substance present in every cell of the body. A coenzyme is a very small molecule that enhances the function of enzymes, particularly in the

More information

3rd Annual Patient Recruitment & Retention in Pharma

3rd Annual Patient Recruitment & Retention in Pharma Amsterdam, 23rd - 24th February 2011 3rd Annual Patient Recruitment & Retention in Pharma Who will I meet there? Chairperson Liz Moench President and CEO MediciGlobal Wolfgang Eglmeier Head Clinical Operations

More information

PROJECT PORTFOLIO MANAGEMENT WORKSHOP: Maximizing Value From Constrained Resources

PROJECT PORTFOLIO MANAGEMENT WORKSHOP: Maximizing Value From Constrained Resources PROJECT PORTFOLIO MANAGEMENT WORKSHOP: Maximizing Value From Constrained Resources WHO SHOULD ATTEND Participants involved in Project Management, Portfolio Management, Strategic & Business Planning, Product

More information

Clinical Trial Logistics

Clinical Trial Logistics BOOK BY 31ST MARCH TO SAVE 100 SMi presents the 8th conference and exhibition series... Clinical Trial Logistics 21ST - 22ND MAY 2014 MARRIOTT REGENTS PARK LONDON, UK EUROPE'S LEADING CLINICAL TRIAL LOGISTICS

More information

CHAPTER FOUR: CLINICAL TRIAL COST AND FUNDING... 30

CHAPTER FOUR: CLINICAL TRIAL COST AND FUNDING... 30 CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 INTENDED AUDIENCE... 2 METHODOLOGY... 2 ANALYST CREDENTIALS... 2 SCOPE OF REPORT... 2 INFORMATION SOURCES...

More information

www.pharmaphorum.com

www.pharmaphorum.com Social media training workshop Driving growth through effective social media use Thistle Marble Arch Hotel, London 12th July 2012 www.pharmaphorum.com A one-day workshop to cover the essentials of effective

More information

FACULTY OF PAIN MEDICINE AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS FACULTY OF PAIN MEDICINE 2016 REFRESHER COURSE DAY

FACULTY OF PAIN MEDICINE AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS FACULTY OF PAIN MEDICINE 2016 REFRESHER COURSE DAY AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS FACULTY OF PAIN MEDICINE 2016 REFRESHER COURSE DAY Crowne Plaza, Auckland, New Zealand Healthcare industry sponsorship and exhibition prospectus 2016

More information

Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form

Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form C H I Cambridge Healthtech Institute s Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form Over 800,000 names segmented by scientific interest Featuring U.S and International

More information

Main Conference Agenda

Main Conference Agenda Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

Business Continuity & Resilience Conference

Business Continuity & Resilience Conference Business Continuity & Resilience Conference Venue: Date: The City, London (TBC) 9 September 2014 Building capacity for resilient growth and development Speakers include: Andrew Gracie Executive Director

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

Pri-Med New York. REGIONAL CONFERENCE November 19 20, 2014 Jacob K. Javits Convention Center. Register today:

Pri-Med New York. REGIONAL CONFERENCE November 19 20, 2014 Jacob K. Javits Convention Center. Register today: Pri-Med New York REGIONAL CONFERENCE November 19 20, 2014 Jacob K. Javits Convention Center Earn up to 14.5 AMA PRA Category 1 Credits or 14.5 AANP contact hours of continuing education. Register today:

More information

Targeting the problem together

Targeting the problem together 18 October, Marriott Grosvenor Square, London postevents.co.uk/fraud Targeting the problem together Associate Sponsor Media Partner Fraud 2012 has been accredited by the CII and can be included as part

More information

Signalling Success: 5th SCI-RSC symposium on kinase inhibitor design. Monday 21 - Tuesday 22 May 2012 Accelrys, Cambridge Science Park, Cambridge, UK

Signalling Success: 5th SCI-RSC symposium on kinase inhibitor design. Monday 21 - Tuesday 22 May 2012 Accelrys, Cambridge Science Park, Cambridge, UK Protein Kinase 2012 Signalling Success: 5th SCI-RSC symposium on kinase inhibitor design Monday 21 - Tuesday 22 May 2012 Accelrys, Cambridge Science Park, Cambridge, UK Organised by SCI s Fine Chemicals

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern

More information

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit 2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China

More information

Predictive Analytics & Filtering for Finance

Predictive Analytics & Filtering for Finance Predictive Analytics & Filtering for Finance 25 28 January, 2016 London Objectives: Scope and Purpose The application of regime-switching models and filtering techniques gain in importance in financial

More information

6 th British Society for Heart Failure Heart Failure Nurse and Healthcare Professional Study Day. Friday 4 March 2016

6 th British Society for Heart Failure Heart Failure Nurse and Healthcare Professional Study Day. Friday 4 March 2016 BRITISH SOCIETY FOR HEART FAILURE BRITISH SOCIETY FOR HEART FAILURE 6 th British Society for Heart Failure Heart Failure Nurse and Healthcare Professional Study Day Friday 4 March 2016 RCN accreditation

More information

Total Market Forecasting in Pharma USA

Total Market Forecasting in Pharma USA Third Annual Total Market Forecasting in Pharma USA Wednesday June 11 and Thursday June 12 2008, Central Philadelphia, PA, USA Forecasting success within a fast-paced and challenging industry Silver sponsor:

More information

Double degrees with University of Sussex, UK

Double degrees with University of Sussex, UK BIOMEDICAL SCIENCE Double degrees with University of Sussex, UK Faculty of Science (International Program), Mahidol University (SIM) has developed Dual Degree Programs in cooperation with University of

More information

8 th BSH Heart Failure Day for Revalidation and Training

8 th BSH Heart Failure Day for Revalidation and Training BRITISH SOCIETY FOR HEART FAILURE BRITISH SOCIETY FOR HEART FAILURE 8 th BSH Heart Failure Day for Revalidation and Training Thursday 3 March 2016 BCS Approved CPD accredited meeting Golden Jubilee Conference

More information

Martin Keogh Acting Chief Operating Officer ALFRED HEALTH, VIC. Dr Ian Scott Director, Department of Internal Medicine & Clinical Epidemiology

Martin Keogh Acting Chief Operating Officer ALFRED HEALTH, VIC. Dr Ian Scott Director, Department of Internal Medicine & Clinical Epidemiology Driving whole of hospital reform to Improve Patient Flow 19th & 20th May, 2015, Oaks on Market Hotel, Melbourne Key Speakers Benefits of attending Colton Miller Nurse Manager, Emergency Department TAMPA

More information

Brain Cross Training Hormesis The Principle of Good Stress

Brain Cross Training Hormesis The Principle of Good Stress Brain Cross Training Hormesis The Principle of Good Stress Mark Ashton Smith Ph.D. 2015 1 CONTENTS Foreword 3 Stress and Homeostasis 4 Stress in Evolution 5 Vitagenes 6 Brain Benefits of Adaptive Cellular

More information

The Genetic Basis of Neurological Disorders

The Genetic Basis of Neurological Disorders The Genetic Basis of Neurological Disorders A complete advanced undergraduate/graduate course with: 22 online lectures by leading authorities Resources for workshops, tutorials, journal clubs, projects

More information

Biomedical Accelerator Fund. Office of Technology Development Harvard University

Biomedical Accelerator Fund. Office of Technology Development Harvard University Biomedical Accelerator Fund Office of Technology Development Harvard University Curtis Keith, Chief Scientific Officer May 21, 2012 Mission of Harvard s Office 2 Organizational Structure of Harvard OTD

More information

Clinical Trial Logistics & Supply

Clinical Trial Logistics & Supply Driving the Industry Forward www.futurepharmaus.com Clinical Trial Logistics & Supply Anticipating and overcoming management and delivery challenges 29th - 30th September 2011, Visiongain Conference Centre,

More information

NO More Heart Disease

NO More Heart Disease NO More Heart Disease Nitric Oxide Information NO is one of the simplest molecules in biology, comprised of just two atoms one atom of nitrogen (N) and one of oxygen (O). Through NO s structure is simple,

More information

Project Finance in the Oil and Gas Industry

Project Finance in the Oil and Gas Industry Book early and SAVE 10% www.clariontraining.com/energy A three-day practical applied training course for Oil and Gas Industry Professionals Get to grips with financial and economic techniques, sources

More information

incisive-training.com/generationasset Generation Asset Analytics and Risk Management Course highlights

incisive-training.com/generationasset Generation Asset Analytics and Risk Management Course highlights Course highlights Apply the latest approaches for modelling energy prices Practical lessons on calibrating models and implementing Monte-Carlo simulations Value generation assets Hedge portfolios of generation

More information

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry The Master Degree in Medical Laboratory Sciences /Clinical Biochemistry, is awarded by the Faculty of Graduate Studies

More information

Made by nature, supported by science. DeerVelvet. Veterinary information. New Zealand Deer Products

Made by nature, supported by science. DeerVelvet. Veterinary information. New Zealand Deer Products Made by nature, supported by science. DeerVelvet Veterinary information New Zealand Deer Products 21503 pet velvet_vet_4_0.indd 1 1/5/09 11:34:32 AM Made by nature, supported by science. A scientific foundation

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

A Workshop Case Study for API Lead Auditors

A Workshop Case Study for API Lead Auditors This is not just a training course but a comprehensive case study! Step 1 Prepare for the Audit ECA Step 2 The Opening Meeting at API Pharma Step 3 Performing the Audit at API Pharma Step 4 The Closing

More information

Anti-aging Products and Services: The Global Market

Anti-aging Products and Services: The Global Market A BCC Research Healthcare Report Services: The Global HLC060A Use this report to: Define and measure the global anti-aging market for the baby boomer population and sales opportunities for health maintenance,

More information

Higher Human Biology Course Specification (C740 76)

Higher Human Biology Course Specification (C740 76) Higher Human Biology Course Specification (C740 76) Valid from August 2014 This edition: April 2014, version 2.0 This specification may be reproduced in whole or in part for educational purposes provided

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association 6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising

More information

SAVE! EARLY BIRD DISCOUNTS ARE AVAILABLE Contact Jasmin Sangha on 020 7004 7560 jasmin.sangha@incisivemedia.com

SAVE! EARLY BIRD DISCOUNTS ARE AVAILABLE Contact Jasmin Sangha on 020 7004 7560 jasmin.sangha@incisivemedia.com 1 March, Millennium Hotel, Mayfair, London SAVE! EARLY BIRD DISCOUNTS ARE AVAILABLE Contact Jasmin Sangha on 020 7004 7560 jasmin.sangha@incisivemedia.com search innovate navigate user engage connect ranking

More information

Dr.Deepak V. Chaturvedi,

Dr.Deepak V. Chaturvedi, Dr.Deepak V. Chaturvedi, M.B.B.S; M.D.(Medicine) Metabolic Physician, Diabetologist, Antiaging, Obesity & Hormones Specialist. Specializing in Bio Identical Hormone Replacement Therapy Evolution from TREATMENT

More information

HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE

HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE HUNTINGTON S DISEASE MULTIDISCIPLINARY CLINIC HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE From gene to treatments The gene that causes Huntington s disease (HD) was discovered in 1993. Since then, enormous

More information

EXHIBITION PROSPECTUS

EXHIBITION PROSPECTUS EXHIBITION PROSPECTUS 25 TH INTERNATIONAL APPLIED GEOCHEMISTRY SYMPOSIUM INCORPORATING THE 35 TH NEW ZEALAND GEOTHERMAL WORKSHOP ROTORUA, NEW ZEALAND 18 21 NOVEMBER 2013 www.gns.cri.nz/iags Lake Rotorua

More information

From The Lab To Your Medicine Cabinet:

From The Lab To Your Medicine Cabinet: From The Lab To Your Medicine Cabinet: A Pharmaceutical Drug s Journey Presented by: Dr. Steven Hansel Sr. Director; Pfizer Moderated by: Sam Gilchrist Ph.D. Candidate; UBC The Drug Development Process

More information

Financial Modelling for PPP/PFI Enhance your modelling capabilities

Financial Modelling for PPP/PFI Enhance your modelling capabilities Definitive Project Managers Guide to Modelling PPP SMi s 10th Conference on Financial Modelling for PPP/PFI Enhance your modelling capabilities Are you taking the right decisions for your PFI project?

More information

Why the FIREFLY? An Overview > Fireflies are lighting the way to drug discovery and patient diagnosis

Why the FIREFLY? An Overview > Fireflies are lighting the way to drug discovery and patient diagnosis Mitochondrial Dysfunction An Overview > Why the FIREFLY? Fireflies are lighting the way to drug discovery and patient diagnosis The Foundation for Mitochondrial Medicine is an organization strategically

More information

Enterprise wide Risk Management for the Energy Industry

Enterprise wide Risk Management for the Energy Industry Course highlights: Creating and implementing an ERM structure Identifying, sourcing and measurement of risk Embedding ERM into the culture of the organisation Advanced practice of ERM The regulatory case

More information

Fundraising and Research Objectives

Fundraising and Research Objectives THE EHE FOUNDATION THE EHE RARE CANCER CHARITY (UK)* THE EHE RARE CANCER FOUNDATION (AUSTRALIA)* Fundraising and Research Objectives Thank you for taking the time to find and engage with our Fundraising

More information

Name Class Date. KEY CONCEPT Mutations are changes in DNA that may or may not affect phenotype. frameshift mutation

Name Class Date. KEY CONCEPT Mutations are changes in DNA that may or may not affect phenotype. frameshift mutation Unit 7 Study Guide Section 8.7: Mutations KEY CONCEPT Mutations are changes in DNA that may or may not affect phenotype. VOCABULARY mutation point mutation frameshift mutation mutagen MAIN IDEA: Some mutations

More information

DYNAMIC HEDGING ESSENTIALS, MASTER CLASS AND WORKSHOP

DYNAMIC HEDGING ESSENTIALS, MASTER CLASS AND WORKSHOP DYNAMIC HEDGING ESSENTIALS, MASTER CLASS AND WORKSHOP Chicago, Illinois August 8 9, 2013 About the course Tremendous advances have been made in the last few years in the area of dynamic hedging of variable

More information

EBiSC the first European bank for induced pluripotent stem cells

EBiSC the first European bank for induced pluripotent stem cells Press Release EBiSC the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)

More information

The Pain & Brain Healing Center

The Pain & Brain Healing Center The Pain & Brain Healing Center Dr. G. FORS, DC, Board-certified Neurologist (IBCN) 1400 131st Ave NE Blaine, MN 55449-763.862.7100 Dear New Patient: Welcome to the Pain &Brain Healing Center. Whether

More information

Terms and Conditions for the Supply of Goods and Services WestOne Virtual Office Group Ltd

Terms and Conditions for the Supply of Goods and Services WestOne Virtual Office Group Ltd Terms and Conditions for the Supply of Goods and Services WestOne Virtual Office Group Ltd 1. General Website Usage 1.1. Welcome to our website. If you continue to browse and use this website you are agreeing

More information

SAND CONTROL COMPLETION PRACTICES

SAND CONTROL COMPLETION PRACTICES PETROSYNC S WELL ENGINERRING SERIES SAND CONTROL COMPLETION PRACTICES Learn to Maximize Productivity with Reliable Equipment 22 February 2016 24 February 2016 Bandung, Indonesia Supported By Course Overview

More information

Tabletting technology for the pharmaceutical industry

Tabletting technology for the pharmaceutical industry Tabletting technology for the pharmaceutical industry A three-day residential course organised by the Royal Pharmaceutical Society of Great Britain in partnership with the Academy of Pharmaceutical Sciences

More information

Why individual membership is valuable to YOU.

Why individual membership is valuable to YOU. Why individual membership is valuable to YOU. The Leading Biotechnology Organization In The Heart of Canada and a strong voice for biotechnology in the Toronto Region, Ontario and Canada. Get Connected!

More information

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute

More information

Cost: 330 Early fee 380 for applications after 22nd September 2007

Cost: 330 Early fee 380 for applications after 22nd September 2007 Target audience: Nurses, physiotherapists, dietitians, exercise and physical activity specialists, cardiologists, general practitioners and other health professionals interested in the practical aspects

More information

MARITIME LAW AND MARINE INSURANCE CLAIMS

MARITIME LAW AND MARINE INSURANCE CLAIMS AN INVITATION TO OUR ANNUAL COURSE ON MARITIME LAW AND MARINE INSURANCE CLAIMS 15-19 SEPTEMBER 2014 PEWTERERS HALL LONDON OBJECTIVE The objective of the course is to provide you with the confidence to

More information

Future of Formulations in Cosmetics

Future of Formulations in Cosmetics The Conference The European cosmetic market continues to be a world leader with a market size almost doubling the US and Asia regions. Despite the difficulties of the economic climate, one thing that does

More information

Faculty of Biological Sciences POSTGRADUATE RESEARCH DEGREES 2014

Faculty of Biological Sciences POSTGRADUATE RESEARCH DEGREES 2014 Faculty of Biological Sciences POSTGRADUATE RESEARCH DEGREES 2014 RESEARCH DEGREES: PHD & MSC BY RESEARCH The Faculty is home to more than 100 academic researchers with expertise right across the biological

More information

Duke Regional Diabetes Symposium 2012

Duke Regional Diabetes Symposium 2012 Duke Regional Diabetes Symposium 2012 July 13, 2012 8:30 AM 4:30 PM North Carolina Research Campus David H. Murdock Core Laboratory Building First Floor Event Room 150 Research Campus Drive Kannapolis,

More information

Course. In association with. Tabletting technology for the pharmaceutical industry

Course. In association with. Tabletting technology for the pharmaceutical industry Course In association with Tabletting technology for the pharmaceutical industry The Møller Centre, Cambridge Monday 19 Wednesday 21 November 2012 Do you work in formulation development or the production

More information

Genetic Tests for Health Purposes

Genetic Tests for Health Purposes Genetic Tests for Health Purposes Genetic Tests for Health Purposes We have all inherited a unique combination of genes from our parents. This original constitution and the influence of various environmental

More information

PGY 206 ELEMENTARY PHYSIOLOGY. (3) An introductory survey course in basic human physiology. Prereq: One semester of college biology.

PGY 206 ELEMENTARY PHYSIOLOGY. (3) An introductory survey course in basic human physiology. Prereq: One semester of college biology. 206 ELEMENTARY PHYSIOLOGY. (3) An introductory survey course in basic human physiology. Prereq: One semester of college biology. 207 CASE STUDIES IN PHYSIOLOGY. (1) Group discussions of clinical cases

More information

Alzheimer s Disease. Leveraging Multiple Data Sources to Maximize the Potential for Recruitment Success. By Loni Branon

Alzheimer s Disease. Leveraging Multiple Data Sources to Maximize the Potential for Recruitment Success. By Loni Branon Alzheimer s Disease Leveraging Multiple Data Sources to Maximize the Potential for Recruitment Success By Loni Branon A2 March 2016 Leveraging Multiple Data Sources to Maximize the Potential for Recruitment

More information

OBSERVATIONAL CLINICAL RESEARCH FOR REAL WORLD EVIDENCE

OBSERVATIONAL CLINICAL RESEARCH FOR REAL WORLD EVIDENCE OBSERVATIONAL CLINICAL RESEARCH FOR REAL WORLD EVIDENCE A two days intensive course to learn the most important and successful factors involved in the planning and design of observational clinical research,

More information

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics

More information

XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015

XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015 XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective May 11 12; 2015 Hotel Hesselet, Nyborg Symposium organizers Morten Blinkenberg, University of

More information

BIOL 1260: PYSIOLOGICAL PHARMACOLOGY, Section 02 PFIZER CLASS SCHEDULE: FALL, 2015

BIOL 1260: PYSIOLOGICAL PHARMACOLOGY, Section 02 PFIZER CLASS SCHEDULE: FALL, 2015 BIOL 1260: PYSIOLOGICAL PHARMACOLOGY, Section 02 PFIZER CLASS SCHEDULE: FALL, 2015 Presents drugs in the context of the diseases they treat. A group of the most commonly prescribed drugs is discussed in

More information

ATIP Avenir Program 2014. Applicant s guide

ATIP Avenir Program 2014. Applicant s guide ATIP Avenir Program 2014 Applicant s guide Important dates: - November 29 th 2013: deadline for the online submission, the mailing of the hard copy of the scientific project, and the letters of recommendation

More information

Petrosync Distinguished Lecturer

Petrosync Distinguished Lecturer Practical Aspects of Reservoir Simulation Optimize Your Reservoir Simulation By Learning Practical Aspects From The Expert! 3th October 204-7th October 204, Kuala Lumpur, Malaysia A lot of Hands on Example,

More information

DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY

DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY Seminar The purpose of this course is to train students the skills of oral presentation about how to deliver seminar in an efficient way. For each talk, a professor

More information

the progressive decline in function and performance which accompanies advancing years

the progressive decline in function and performance which accompanies advancing years Ageing: the progressive decline in function and performance which accompanies advancing years The survival rate against age can be shown in the following graph: Percentage Survival verses Age Percentage

More information